Literature DB >> 16494846

Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes.

Anisha Gupte1, Silvia Mora.   

Abstract

In adipocytes, the Cbl/CAP dependent signaling pathway has been involved in regulating insulin-stimulated glucose uptake. We investigated activation of Cbl and its downstream effector TC10 in cardiac and skeletal muscle of Balb/C mice. Insulin administration resulted in Cbl phosphorylation in cardiac, skeletal muscle, and adipose tissue. Subsequent TC10 activation was detected only in heart and adipose tissue. c-Cbl and CAP gene expression was significantly reduced in the heart tissue of streptozotocin-induced diabetic animals, whereas no change was observed for other components of the pathway. No changes in Cbl expression were detected in hindlimb muscle. In leptin-/- obese mice Cbl expression in heart and adipose tissue was maintained, although insulin-mediated Cbl phosphorylation and subsequent TC10 activation were significantly reduced. In conclusion, our data demonstrate that Cbl/CAP/TC10 insulin signaling pathway is active in cardiac muscle and impaired during obesity and insulin deficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16494846     DOI: 10.1016/j.bbrc.2006.02.023

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle.

Authors:  I Chopra; H F Li; H Wang; K A Webster
Journal:  Diabetologia       Date:  2011-12-30       Impact factor: 10.122

2.  Enhanced fasting glucose turnover in mice with disrupted action of TUG protein in skeletal muscle.

Authors:  Michael G Löffler; Andreas L Birkenfeld; Katerina M Philbrick; Jonathan P Belman; Estifanos N Habtemichael; Carmen J Booth; Carlos M Castorena; Cheol Soo Choi; Francois R Jornayvaz; Brandon M Gassaway; Hui-Young Lee; Gregory D Cartee; William Philbrick; Gerald I Shulman; Varman T Samuel; Jonathan S Bogan
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

3.  Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity.

Authors:  Jenny Lee; Ya Xu; Li Lu; Bryan Bergman; J Wayne Leitner; Clifford Greyson; Boris Draznin; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

4.  TC10 controls human myofibril organization and is activated by the sarcomeric RhoGEF obscurin.

Authors:  Marjorie Coisy-Quivy; Olivia Touzet; Annick Bourret; Robert A Hipskind; Jacques Mercier; Philippe Fort; Alexandre Philips
Journal:  J Cell Sci       Date:  2009-03-03       Impact factor: 5.285

5.  Therapeutic properties of Scutellaria baicalensis in db/db mice evaluated using Connectivity Map and network pharmacology.

Authors:  Bu-Yeo Kim; Kwang Hoon Song; Chi-Yeon Lim; Su-In Cho
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

6.  Insulin-stimulated endoproteolytic TUG cleavage links energy expenditure with glucose uptake.

Authors:  Estifanos N Habtemichael; Don T Li; João Paulo Camporez; Xavier O Westergaard; Chloe I Sales; Xinran Liu; Francesc López-Giráldez; Stephen G DeVries; Hanbing Li; Diana M Ruiz; Kenny Y Wang; Bhavesh S Sayal; Sofia González Zapata; Pamela Dann; Stacey N Brown; Sandro Hirabara; Daniel F Vatner; Leigh Goedeke; William Philbrick; Gerald I Shulman; Jonathan S Bogan
Journal:  Nat Metab       Date:  2021-03-08

7.  Mitochondrial dysfunction in insulin resistance: differential contributions of chronic insulin and saturated fatty acid exposure in muscle cells.

Authors:  Chenjing Yang; Cho Cho Aye; Xiaoxin Li; Angels Diaz Ramos; Antonio Zorzano; Silvia Mora
Journal:  Biosci Rep       Date:  2012-10       Impact factor: 3.840

8.  Cbl downregulation increases RBP4 expression in adipocytes of female mice.

Authors:  Gulizar Issa Ameen; Silvia Mora
Journal:  J Endocrinol       Date:  2017-11-07       Impact factor: 4.286

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.